R. Pranata

Infectious Diseases · 2020

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom R. Pranata trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Organization (in Infectious Diseases)

Papers from R. Pranata's perspective

Ordered by how strongly the researchers R. Pranata trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Angiotensin-converting enzyme 2 protects from severe acute lung failure (Nature)
  2. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus (Journal of Virology)
  3. Clinical features and treatment of COVID‐19 patients in northeast Chongqing (Journal of Medical Virology)
  4. Diabetes is a risk factor for the progression and prognosis of COVID‐19 (Diabetes/Metabolism Research Reviews)
  5. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (Intensive Care Medicine)
  6. Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia (Emerging Microbes and Infections)
  7. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (International Journal of Oral Science)
  8. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression (Diabetes & metabolic syndrome)
  9. [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi)
  10. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)

Their papers